TY - JOUR
T1 - National drug policies to local formulary decisions in Thailand, China, and Australia: Drug listing changes and opportunities
AU - Yoongthong, Worasuda
AU - Hu, Shanlian
AU - Whitty, Jennifer A.
AU - Wibulpolprasert, Suwit
AU - Sukantho, Kitti
AU - Thienthawee, Wannisa
AU - Han, Huixue
AU - Scuffham, Paul A.
PY - 2012/1
Y1 - 2012/1
N2 - This commentary is aimed at summarizing the second plenary session presented at the ISPOR 4th Asia-Pacific Conference held in 2010 and compare the issues on drug listing of Thailand, China, and Australia. These countries have substantially different demographic and economic characteristics and health-care financing structures and are in different phases of development of health technology assessment (HTA) (Table 1). Expenditure data shown in Table 1 for 2008 were converted at purchasing power parity to US dollars.
AB - This commentary is aimed at summarizing the second plenary session presented at the ISPOR 4th Asia-Pacific Conference held in 2010 and compare the issues on drug listing of Thailand, China, and Australia. These countries have substantially different demographic and economic characteristics and health-care financing structures and are in different phases of development of health technology assessment (HTA) (Table 1). Expenditure data shown in Table 1 for 2008 were converted at purchasing power parity to US dollars.
U2 - 10.1016/j.jval.2011.11.003
DO - 10.1016/j.jval.2011.11.003
M3 - Article
VL - 15
SP - S126-S131
JO - Value in Health
JF - Value in Health
SN - 1098-3015
IS - 1
ER -